Department of Physiology and Pathophysiology, Peking University Health Science Center, Key Laboratory of Molecular Cardiovascular Sciences of Education Ministry, Beijing 100191, China.
PPAR Res. 2011;2011:164925. doi: 10.1155/2011/164925. Epub 2011 Nov 14.
Hepatic nuclear factor 4α (HNF4α) modulates the transcriptional activation of numerous metabolic genes in liver. In this study, gene-array analysis revealed that HNF4α overexpression increased peroxisome proliferator-activated receptorγ (PPARγ) greatly in cultured rat primary hepatocytes. PPAR-response-element-driven reporter gene expression could be elevated by HNF4α. Bioinformatics analysis revealed a high-affinity HNF4α binding site in the human PPARγ2 promoter and in vitro experiments showed that this promoter could be transactivated by HNF4α. The presence of HNF4α on the promoter was then confirmed by ChIP assay. In vivo, hepatic overexpression of HNF4α decreased cholesterol levels both in plasma and liver and several hepatic genes related to cholesterol metabolism, including scavenger receptor BI (SR-BI), were upregulated. The upregulation of SR-BI by HNF4α could be inhibited by a PPARγ antagonist in vitro. In conclusion, HNF4α regulates cholesterol metabolism in rat by modulating the expression of SR-BI in the liver, in which the upregulation of PPARγ was involved.
肝核因子 4α(HNF4α)调节肝脏中许多代谢基因的转录激活。在这项研究中,基因芯片分析显示,HNF4α 过表达可大大增加培养的大鼠原代肝细胞中过氧化物酶体增殖物激活受体γ(PPARγ)的含量。HNF4α 可增加 PPAR 反应元件驱动的报告基因表达。生物信息学分析显示,人 PPARγ2 启动子中存在高亲和力的 HNF4α 结合位点,体外实验表明该启动子可被 HNF4α 反式激活。ChIP 检测进一步证实了启动子上 HNF4α 的存在。在体内,HNF4α 在肝脏中的过表达可降低血浆和肝脏中的胆固醇水平,以及几种与胆固醇代谢相关的肝基因,包括清道夫受体 BI(SR-BI)。HNF4α 可上调 SR-BI,这一过程可被 PPARγ 拮抗剂在体外抑制。总之,HNF4α 通过调节肝脏中 SR-BI 的表达来调节大鼠的胆固醇代谢,其中涉及到 PPARγ 的上调。